Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

National, regional, and worldwide estimates of stillbirth rates in 2015, with trends from 2000: a systematic analysis.

Blencowe H, Cousens S, Jassir FB, Say L, Chou D, Mathers C, Hogan D, Shiekh S, Qureshi ZU, You D, Lawn JE; Lancet Stillbirth Epidemiology Investigator Group.

Lancet Glob Health. 2016 Feb;4(2):e98-e108. doi: 10.1016/S2214-109X(15)00275-2. Epub 2016 Jan 19. Erratum in: Lancet Glob Health. 2016 Mar;4(3):e164.

2.

Stillbirths: rates, risk factors, and acceleration towards 2030.

Lawn JE, Blencowe H, Waiswa P, Amouzou A, Mathers C, Hogan D, Flenady V, Fr√łen JF, Qureshi ZU, Calderwood C, Shiekh S, Jassir FB, You D, McClure EM, Mathai M, Cousens S; Lancet Ending Preventable Stillbirths Series study group; Lancet Stillbirth Epidemiology investigator group.

Lancet. 2016 Feb 6;387(10018):587-603. doi: 10.1016/S0140-6736(15)00837-5. Epub 2016 Jan 19. Review.

PMID:
26794078
3.

Antitumor activity of lentivirus-mediated interleukin -12 gene modified dendritic cells in human lung cancer in vitro.

Ahmed Ali HA, Di J, Mei W, Zhang YC, Li Y, Du ZW, Zhang GZ.

Asian Pac J Cancer Prev. 2014;15(2):611-6.

Supplemental Content

Loading ...
Support Center